“Anti-SARS-CoV-2 Inactivated Vaccine in Patients With ANCA-Associated Vasculitis: Immunogenicity, Safety, Antibody Decay and the Booster Dose”. 2022. Clinics 78 (November): 100150. https://doi.org/10.1016/j.clinsp.2022.100150.